Pfizer’s 4.9% Yield: A Contrarian Buy Near 1-Year Lows (NYSE:PFE)


Trading Begins As The Markets Open Monday Morning

Michael M. Santiago

Shares of Pfizer (NYSE:PFE) are at risk of dropping to new selling pressure after the drug manufacturer cut its earnings and revenue forecast for FY 2023 last week due to plunging COVID-19 vaccine sales. The warning



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *